Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease

Authors

  • Mengxuan Chen The University of Toledo Department of Medicine Author
  • Yan Ge Division of Nephrology, University of Toledo College of Medicine Author
  • Lance Dworkin Division of Nephrology, University of Toledo College of Medicine Author https://orcid.org/0000-0002-2471-5989
  • Rujun Gong Division of Nephrology, University of Toledo College of Medicine Author

DOI:

https://doi.org/10.46570/utjms-2025-1352

Keywords:

GSK3beta hyperactivity, hyperinsulinemia, diabetic kidney disease

Downloads

Published

2025-06-30

Issue

Vol. 13 No. S3 (2025): The 2024 Dr. Lance D. Dworkin Department of Medicine Research Symposium

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium

License

Copyright (c) 2025 Mengxuan Chen, Yan Ge, Lance Dworkin, Rujun Gong (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease. Translation. 2025;13(S3). doi:10.46570/utjms-2025-1352

Most read articles by the same author(s)